
Associated Press - December 3, 2003
"We have got to do everything we possibly can to make sure we put the support in but also reduce the price of the drugs for treatment for people in some of the poorest countries in the world," Blair told the House of Commons.
"And we are working with the drug companies to do this because if the right combination of measures on prevention and treatment are given then there is no doubt we can make a significant difference to this problem," Blair said.
Blair added that the U.K. was now the second biggest donor after the U.S. to the UNAIDS fund, a U.N. program dedicated to fighting HIV/AIDS.
"Our funding has actually increased sevenfold over the past few years -it is almost 300 million pounds in this financial year," Blair said.
031203
AP031217
Copyright © 2003 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .